NEW YORK (GenomeWeb) – Claritas Genomics announced today that it has received New York State Department of Health approval to start offering its Clinical Exome and Pediatric Neurology Region of Interest diagnostic tests in New York.

The company — which was created by Boston Children's Hospital and Cincinnati Children's Hospital in partnership with Cerner, Wuxi NextCode Genomics, and Thermo Fisher Scientific — offers the Clinical Exome test for people with complex, multi-systemic symptoms, or conditions with genetic and phenotypic heterogeneity.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

CNN reports that researchers have tied a new variant to opioid addiction risk.

Organoids derived from patients' tumors may help determine what chemotherapy treatment patients would benefit from, according to New Scientist.

An initiative from GenomeAsia 100K hopes to increase the number of South Asians in genetic research, according to NBC News.

In Science this week: genomic analysis of ancient and modern horses indicates population turnover, and more.